Reginster, Jean-Yves; Gillet, Pierre; Sedrine, Wafa Ben; … - In: PharmacoEconomics 15 (1999) 5, pp. 507-514
Objective: Osteoporosis-related costs are now considered a major burden for health authorities in most developed countries. An accurate and exhaustive evaluation of these costs would be a major contribution to health economic studies evaluating the efficiency of screening and prevention...